Search research articles
Contact Us
Filters
Showing results (41-50 of 58) with videos related to
Page
of 6
Sort By:
Journal of Pediatric Gastroenterology and Nutrition
|
January 25, 2020
Management of Hepatitis B Virus Infection and Prevention of Hepatitis B Virus Reactivation in Children With Acquired Immunodeficiencies or Undergoing Immune Suppressive, Cytotoxic, or Biological Modifier Therapies
Giuseppe Indolfi, Mona Abdel-Hady, Sanjay Bansal, et al.
Hepatology (Baltimore, Md.)
|
December 21, 2016
The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection
William F Balistreri, Karen F Murray, Philip Rosenthal, et al.
Blood
|
July 24, 2010
Heat shock protein 90 regulates the expression of Wilms tumor 1 protein in myeloid leukemias
Hima Bansal, Sanjay Bansal, Manjeet Rao, et al.
Hepatology (Baltimore, Md.)
|
June 21, 2019
Ledipasvir-Sofosbuvir for 12 Weeks in Children 3 to <6 Years Old With Chronic Hepatitis C
Kathleen B Schwarz, Philip Rosenthal, Karen F Murray, et al.
Journal of Viral Hepatitis
|
October 19, 2020
Persistent Hepatitis E virus infection across England and Wales 2009-2017: Demography, virology and outcomes
Michael Ankcorn, Bengü Said, Dilys Morgan, et al.
Hepatology (Baltimore, Md.)
|
May 10, 2021
Human Leukocyte Antigen Profile Predicts Severity of Autoimmune Liver Disease in Children of European Ancestry
Yun Ma, Haibin Su, Muhammed Yuksel, et al.
Plos One
|
January 4, 2013
Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganization
J Saadi Imam, Jason R Plyler, Hima Bansal, et al.
Journal of the National Cancer Institute
|
April 17, 2019
TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer
Utpal K Mukhopadhyay, Chetan C Oturkar, Christina Adams, et al.
Hepatology (Baltimore, Md.)
|
August 3, 2018
Safety and Efficacy of Ledipasvir-Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6-11
Karen F Murray, William F Balistreri, Sanjay Bansal, et al.
Hepatology (Baltimore, Md.)
|
June 22, 2019
Sofosbuvir and Ribavirin Therapy for Children Aged 3 to <12 Years With Hepatitis C Virus Genotype 2 or 3 Infection
Philip Rosenthal, Kathleen B Schwarz, Regino P Gonzalez-Peralta, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 58) with videos related to
Sort By:
Page
of 6
Journal of Pediatric Gastroenterology and Nutrition
|
January 25, 2020
Management of Hepatitis B Virus Infection and Prevention of Hepatitis B Virus Reactivation in Children With Acquired Immunodeficiencies or Undergoing Immune Suppressive, Cytotoxic, or Biological Modifier Therapies
Giuseppe Indolfi, Mona Abdel-Hady, Sanjay Bansal, et al.
Hepatology (Baltimore, Md.)
|
December 21, 2016
The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection
William F Balistreri, Karen F Murray, Philip Rosenthal, et al.
Blood
|
July 24, 2010
Heat shock protein 90 regulates the expression of Wilms tumor 1 protein in myeloid leukemias
Hima Bansal, Sanjay Bansal, Manjeet Rao, et al.
Hepatology (Baltimore, Md.)
|
June 21, 2019
Ledipasvir-Sofosbuvir for 12 Weeks in Children 3 to <6 Years Old With Chronic Hepatitis C
Kathleen B Schwarz, Philip Rosenthal, Karen F Murray, et al.
Journal of Viral Hepatitis
|
October 19, 2020
Persistent Hepatitis E virus infection across England and Wales 2009-2017: Demography, virology and outcomes
Michael Ankcorn, Bengü Said, Dilys Morgan, et al.
Hepatology (Baltimore, Md.)
|
May 10, 2021
Human Leukocyte Antigen Profile Predicts Severity of Autoimmune Liver Disease in Children of European Ancestry
Yun Ma, Haibin Su, Muhammed Yuksel, et al.
Plos One
|
January 4, 2013
Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganization
J Saadi Imam, Jason R Plyler, Hima Bansal, et al.
Journal of the National Cancer Institute
|
April 17, 2019
TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer
Utpal K Mukhopadhyay, Chetan C Oturkar, Christina Adams, et al.
Hepatology (Baltimore, Md.)
|
August 3, 2018
Safety and Efficacy of Ledipasvir-Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6-11
Karen F Murray, William F Balistreri, Sanjay Bansal, et al.
Hepatology (Baltimore, Md.)
|
June 22, 2019
Sofosbuvir and Ribavirin Therapy for Children Aged 3 to <12 Years With Hepatitis C Virus Genotype 2 or 3 Infection
Philip Rosenthal, Kathleen B Schwarz, Regino P Gonzalez-Peralta, et al.
Page
of 6